share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Director Kewalramani Reshma

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Director Kewalramani Reshma

Ginkgo Bioworks | 4：持股變動聲明-董事 Kewalramani Reshma
美股sec公告 ·  06/15 04:28
牛牛AI助理已提取核心訊息
Reshma Kewalramani, associated with Ginkgo Bioworks Holdings, Inc. [DNA], executed a transaction on 06/12/2024 involving the acquisition of 105,263 shares of Class A Common Stock. The transaction, coded as 'M' indicating an exercise or conversion of derivative security, resulted in Kewalramani holding a total of 186,002 direct shares post-transaction. The action reflects a significant increase in Kewalramani's stake in the company, although the transaction price was not disclosed.
Reshma Kewalramani, associated with Ginkgo Bioworks Holdings, Inc. [DNA], executed a transaction on 06/12/2024 involving the acquisition of 105,263 shares of Class A Common Stock. The transaction, coded as 'M' indicating an exercise or conversion of derivative security, resulted in Kewalramani holding a total of 186,002 direct shares post-transaction. The action reflects a significant increase in Kewalramani's stake in the company, although the transaction price was not disclosed.
Reshma Kewalramani，隸屬於Ginkgo Bioworks Holdings，Inc. [DNA]，於2024年06月12日執行了一項交易，涉及收購105,263股A類普通股。該交易被編碼爲'M'，表示衍生證券的行權或轉換，使Kewalramani在交易後持有總數爲186,002的直接股份。此舉反映Kewalramani在公司的股份顯著增加，儘管交易價格未披露。
Reshma Kewalramani，隸屬於Ginkgo Bioworks Holdings，Inc. [DNA]，於2024年06月12日執行了一項交易，涉及收購105,263股A類普通股。該交易被編碼爲'M'，表示衍生證券的行權或轉換，使Kewalramani在交易後持有總數爲186,002的直接股份。此舉反映Kewalramani在公司的股份顯著增加，儘管交易價格未披露。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。